{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:31:17Z","timestamp":1793241077569,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>With the progressive and ever-increasing antibacterial resistance pathway, the need for novel antibiotic design becomes critical. Sulfonamides are one of the more effective antibiotics against bacteria. In this work, several novel sulfonamide hybrids including coumarin and isoxazole group were synthesized in five steps starting from coumarin-3-carboxylic acid and 3-amino-5-methyl isoxazole and assayed for antibacterial activity. The samples were obtained in good to high yield and characterized by FT-IR,<jats:sup>13<\/jats:sup>C-NMR,<jats:sup>1<\/jats:sup>H-NMR, CHN and melting point techniques. 3D-QSAR is a fast, easy, cost-effective, and high throughput screening method to predict the effect of the compound's efficacy, which notably decreases the needed price for experimental drug assay. The 3D-QSAR model displayed acceptable predictive and descriptive capability to find r2 and q2 the pMIC of the designed compound. Key descriptors, which robustly depend on antibacterial activity, perhaps were explained by this method. According to this model, among the synthesized sulfonamide hybrids,<jats:bold>9b<\/jats:bold>and<jats:bold>9f<\/jats:bold>had the highest effect on the gram-negative and gram-positive bacteria based on the pMIC. The 3D-QSAR results were confirmed in the experimental assays, demonstrating that our model is useful for developing new antibacterial agents. The work proposes a computationally-driven strategy for designing and discovering new sulfonamide scaffold for bacterial inhibition.<\/jats:p>","DOI":"10.1038\/s41598-021-99618-w","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T10:18:43Z","timestamp":1633947523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Synthesis of some novel coumarin isoxazol sulfonamide hybrid compounds, 3D-QSAR studies, and antibacterial evaluation"],"prefix":"10.1038","volume":"11","author":[{"given":"Sheida Nasr","family":"Esfahani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Damavandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahrasadat","family":"Nazifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Salari-Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Massah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"99618_CR1","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/s41598-021-82009-6","volume":"11","author":"A Salari-jazi","year":"2021","unstructured":"Salari-jazi, A., Mahnam, K., Sadeghi, P., Damavandi, M. S. & Faghri, J. Discovery of potential inhibitors against New Delhi metallo-\u03b2-lactamase-1 from natural compounds: In silico-based methods. Sci. Rep. 11, 2390 (2021).","journal-title":"Sci. Rep."},{"key":"99618_CR2","doi-asserted-by":"publisher","first-page":"10401","DOI":"10.1021\/acsomega.0c00280","volume":"5","author":"RA Azzam","year":"2020","unstructured":"Azzam, R. A., Elsayed, R. E. & Elgemeie, G. H. Design, synthesis, and antimicrobial evaluation of a new series of N-sulfonamide 2-pyridones as dual inhibitors of DHPS and DHFR enzymes. ACS Omega 5, 10401\u201310414 (2020).","journal-title":"ACS Omega"},{"key":"99618_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ejmech.2015.01.008","volume":"92","author":"J Li","year":"2015","unstructured":"Li, J. et al. Design, synthesis and pharmacological evaluation of novel N-(2-(1,1-dimethyl-5,7-dioxo-4,6-diazaspiro[2.4]heptan-6-yl)ethyl) sulfonamide derivatives as potential anticonvulsant agents. Eur. J. Med. Chem. 92, 370\u20136 (2015).","journal-title":"Eur. J. Med. Chem."},{"key":"99618_CR4","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1016\/j.tet.2014.03.038","volume":"70","author":"AK Ganguly","year":"2014","unstructured":"Ganguly, A. K. et al. Structural optimization of cyclic sulfonamide based novel HIV-1 protease inhibitors to picomolar affinities guided by X-ray crystallographic analysis. Tetrahedron 70, 2894\u20132904 (2014).","journal-title":"Tetrahedron"},{"key":"99618_CR5","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1016\/j.bmc.2013.05.043","volume":"21","author":"X Ning","year":"2013","unstructured":"Ning, X. et al. Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury. Bioorg. Med. Chem. 21, 5589\u20135597 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"99618_CR6","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1021\/jm00091a018","volume":"35","author":"H Yoshino","year":"1992","unstructured":"Yoshino, H. et al. Novel sulfonamides as potential, systemically active antitumor agents. J. Med. Chem. 35, 2496\u20132497 (1992).","journal-title":"J. Med. Chem."},{"key":"99618_CR7","first-page":"565","volume":"16","author":"A Pesaran Seiied Bonakdar","year":"2017","unstructured":"Pesaran Seiied Bonakdar, A., Vafaei, F., Farokhpour, M., Nasr Esfahani, M. H. & Massah, A. R. Synthesis and anticancer activity assay of novel chalcone-sulfonamide derivatives. Iran J. Pharm. Res. 16, 565\u20138 (2017).","journal-title":"Iran J. Pharm. Res."},{"key":"99618_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/1389557516666160801094919","volume":"18","author":"D Srikrishna","year":"2018","unstructured":"Srikrishna, D., Godugu, C. & Dubey, P. K. A review on pharmacological properties of coumarins. Min. Rev. Med. Chem. 18, 113\u2013141 (2018).","journal-title":"Min. Rev. Med. Chem."},{"key":"99618_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11094-018-1756-y","volume":"52","author":"N Mostajeran","year":"2018","unstructured":"Mostajeran, N., Arshad, F. A., Aliyan, H. & Massah, A. R. Solvent-free synthesis and antibacterial evaluation of novel coumarin sulfonamides. Pharm. Chem. J. 52, 1\u20137 (2018).","journal-title":"Pharm. Chem. J."},{"key":"99618_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1515\/znc-2005-9-1006","volume":"60","author":"SM de Souza","year":"2005","unstructured":"de Souza, S. M., Delle Monache, F. & Sm\u00e2nia, A. Jr. Antibacterial activity of coumarins. Z. Naturforsch. C J. Biosci. 60, 693\u2013700 (2005).","journal-title":"Z. Naturforsch. C J. Biosci."},{"key":"99618_CR11","doi-asserted-by":"publisher","first-page":"e02615","DOI":"10.1016\/j.heliyon.2019.e02615","volume":"5","author":"MS Khan","year":"2019","unstructured":"Khan, M. S., Agrawal, R., Ubaidullah, M., Hassan, M. I. & Tarannum, N. Design, synthesis and validation of anti-microbial coumarin derivatives: An efficient green approach. Heliyon 5, e02615 (2019).","journal-title":"Heliyon"},{"key":"99618_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.17159\/0379-4350\/2019\/v72a32","volume":"72","author":"CG Naik","year":"2019","unstructured":"Naik, C. G., Malik, G. M. & Parekh, H. M. Novel coumarin derivatives: synthesis, characterization and antimicrobial activity. S. Afr. J. Chem. 72, 248\u2013252 (2019).","journal-title":"S. Afr. J. Chem."},{"key":"99618_CR13","doi-asserted-by":"publisher","first-page":"e342-e","DOI":"10.1371\/journal.pmed.0020342","volume":"2","author":"M Greaves","year":"2005","unstructured":"Greaves, M. Pharmacogenetics in the management of coumarin anticoagulant therapy: the way forward or an expensive diversion?. PLoS Med. 2, e342-e (2005).","journal-title":"PLoS Med."},{"key":"99618_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1039\/C4RA11733F","volume":"5","author":"G Mazzone","year":"2015","unstructured":"Mazzone, G., Malaj, N., Galano, A., Russo, N. & Toscano, M. Antioxidant properties of several coumarin\u2013chalcone hybrids from theoretical insights. RSC Adv. 5, 565\u2013575 (2015).","journal-title":"RSC Adv."},{"key":"99618_CR15","doi-asserted-by":"crossref","unstructured":"de Ara\u00fajo RS, Guerra FQ, de OLE, de Simone CA, Tavares JF, Scotti L, et al. Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity. Int J Mol Sci. 14, 1293\u2013309 (2013).","DOI":"10.3390\/ijms14011293"},{"key":"99618_CR16","doi-asserted-by":"crossref","unstructured":"Chikkula KV, S R. Isoxazole 2017 A potent pharmacophore. Int. J. Pharm. Pharm. Sci. 9, 13\u201324 (2017).","DOI":"10.22159\/ijpps.2017.v9i7.19097"},{"key":"99618_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/0394632017724320","volume":"30","author":"SSR Mani","year":"2017","unstructured":"Mani, S. S. R. & Iyyadurai, R. Cloxacillin induced agranulocytosis: A rare adverse event of a commonly used antibiotic. Int. J. Immunopathol. Pharmacol. 30, 297\u2013301 (2017).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"99618_CR18","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1021\/acsmedchemlett.7b00200","volume":"8","author":"JC Lainson","year":"2017","unstructured":"Lainson, J. C. et al. Synthetic antibacterial peptide exhibits synergy with oxacillin against MRSA. ACS Med. Chem. Lett. 8, 853\u2013857 (2017).","journal-title":"ACS Med. Chem. Lett."},{"key":"99618_CR19","doi-asserted-by":"crossref","unstructured":"Sathish Kumar K, Chityala VK, Subhashini NJP, Prashanthi Y, Shivaraj. Synthesis, Characterization, and Biological and Cytotoxic Studies of Copper(II), Nickel(II), and Zinc(II) Binary Complexes of 3-Amino-5-methyl Isoxazole Schiff Base. ISRN Inorganic Chemistry. 2013, 562082 (2013).","DOI":"10.1155\/2013\/562082"},{"key":"99618_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/molecules21010028","volume":"21","author":"EN Agbo","year":"2015","unstructured":"Agbo, E. N., Makhafola, T. J., Choong, Y. S., Mphahlele, M. J. & Ramasami, P. Synthesis, biological evaluation and molecular docking studies of 6-Aryl-2-styrylquinazolin-4(3H)-Ones. Molecules 21, 28 (2015).","journal-title":"Molecules"},{"key":"99618_CR21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/17512433.2017.1345623","volume":"10","author":"G Schoretsanitis","year":"2017","unstructured":"Schoretsanitis, G., Spina, E., Hiemke, C. & de Leon, J. A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone. Expert Rev. Clin. Pharmacol. 10, 965\u2013981 (2017).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"99618_CR22","doi-asserted-by":"publisher","first-page":"12690","DOI":"10.1038\/s41598-017-12696-7","volume":"7","author":"N Zhao","year":"2017","unstructured":"Zhao, N. et al. Greenhouse and field evaluation of isoxaflutole for weed control in maize in China. Sci. Rep. 7, 12690 (2017).","journal-title":"Sci. Rep."},{"key":"99618_CR23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.20452\/pamw.1131","volume":"122","author":"D Golicki","year":"2012","unstructured":"Golicki, D. et al. Leflunomide in monotherapy of rheumatoid arthritis: Meta-analysis of randomized trials. Pol. Arch. Med. Wewn. 122, 22\u201332 (2012).","journal-title":"Pol. Arch. Med. Wewn."},{"key":"99618_CR24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2174\/1385272823666191021124443","volume":"18","author":"VS Gontijo","year":"2020","unstructured":"Gontijo, V. S. et al. Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases. Curr. Neuropharmacol. 18, 348\u2013407 (2020).","journal-title":"Curr. Neuropharmacol."},{"key":"99618_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1515\/hc-2020-0008","volume":"26","author":"A Irfan","year":"2020","unstructured":"Irfan, A. et al. Coumarin sulfonamide derivatives: An emerging class of therapeutic agents. Heterocycl. Commun. 26, 46\u201359 (2020).","journal-title":"Heterocycl. Commun."},{"key":"99618_CR26","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1021\/jm501314c","volume":"57","author":"M Bozdag","year":"2014","unstructured":"Bozdag, M. et al. Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. J. Med. Chem. 57, 9152\u20139167 (2014).","journal-title":"J. Med. Chem."},{"key":"99618_CR27","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/14756366.2018.1477137","volume":"33","author":"A Sabt","year":"2018","unstructured":"Sabt, A. et al. Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies. J. Enzyme Inhibit. Med. Chem. 33, 1095\u2013107 (2018).","journal-title":"J. Enzyme Inhibit. Med. Chem."},{"key":"99618_CR28","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1021\/acs.jmedchem.5b00523","volume":"58","author":"A Grandane","year":"2015","unstructured":"Grandane, A. et al. 6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells. J. Med. Chem. 58, 3975\u20133983 (2015).","journal-title":"J. Med. Chem."},{"key":"99618_CR29","first-page":"881","volume":"13","author":"M Saeedi","year":"2014","unstructured":"Saeedi, M. et al. Synthesis and biological investigation of some novel sulfonamide and amide derivatives containing coumarin moieties. Iran. J. Pharm. Res. 13, 881\u2013892 (2014).","journal-title":"Iran. J. Pharm. Res."},{"key":"99618_CR30","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/14756360600810340","volume":"21","author":"ZH Chohan","year":"2006","unstructured":"Chohan, Z. H., Shaikh, A. U., Rauf, A. & Supuran, C. T. Antibacterial, antifungal and cytotoxic properties of novel N-substituted sulfonamides from 4-hydroxycoumarin. J. Enzyme Inhib. Med. Chem. 21, 741\u2013748 (2006).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"99618_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/18715230113129990019","volume":"13","author":"R Bartzatt","year":"2014","unstructured":"Bartzatt, R. Drug analogs of COX-2 selective inhibitors lumiracoxib and valdecoxib derived from in silico search and optimization. Antiinflamm. Antiallergy Agents Med. Chem. 13, 17\u201328 (2014).","journal-title":"Antiinflamm. Antiallergy Agents Med. Chem."},{"key":"99618_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/WNF.0000000000000208","volume":"40","author":"M Buoli","year":"2017","unstructured":"Buoli, M., Grassi, S., Ciappolino, V., Serati, M. & Altamura, A. C. The use of zonisamide for the treatment of psychiatric disorders: A systematic review. Clin. Neuropharmacol. 40, 85\u201392 (2017).","journal-title":"Clin. Neuropharmacol."},{"key":"99618_CR33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/dom.12275","volume":"16","author":"JH Shin","year":"2014","unstructured":"Shin, J. H., Gadde, K. M., \u00d8stbye, T. & Bray, G. A. Weight changes in obese adults 6-months after discontinuation of double-blind zonisamide or placebo treatment. Diabetes Obes. Metab. 16, 766\u2013768 (2014).","journal-title":"Diabetes Obes. Metab."},{"key":"99618_CR34","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1021\/tx500267x","volume":"27","author":"M Majewsky","year":"2014","unstructured":"Majewsky, M. et al. Antibacterial activity of sulfamethoxazole transformation products (TPs): General relevance for sulfonamide TPs modified at the para position. Chem. Res. Toxicol. 27, 1821\u20131828 (2014).","journal-title":"Chem. Res. Toxicol."},{"key":"99618_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2174\/1570180813666161026153743","volume":"14","author":"K Abdellatif","year":"2017","unstructured":"Abdellatif, K., Abdelgawad, M., Elshemy, H., Kahk, N. & El Amir, D. Design, synthesis, antioxidant and anticancer activity of new coumarin derivatives linked with thiazole, isoxazole or pyrazole moiety. Lett.Drug Des. Discov. 14, 66 (2017).","journal-title":"Lett.Drug Des. Discov."},{"key":"99618_CR36","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1080\/00397911.2016.1242748","volume":"46","author":"G Suresh","year":"2016","unstructured":"Suresh, G., Venkata Nadh, R., Srinivasu, N. & Kaushal, K. Novel coumarin isoxazoline derivatives: Synthesis and study of antibacterial activities. Synth. Commun. 46, 1972\u20131980 (2016).","journal-title":"Synth. Commun."},{"key":"99618_CR37","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1016\/j.bmcl.2014.07.031","volume":"24","author":"UR Shakeel","year":"2014","unstructured":"Shakeel, U. R. et al. Synthesis and biological evaluation of novel isoxazoles and triazoles linked 6-hydroxycoumarin as potent cytotoxic agents. Bioorg. Med. Chem. Lett. 24, 4243\u20136 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"99618_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","volume":"47","author":"JA DiMasi","year":"2016","unstructured":"DiMasi, J. A., Grabowski, H. G. & Hansen, R. W. Innovation in the pharmaceutical industry: New estimates of R&D costs. J. Health Econ. 47, 20\u201333 (2016).","journal-title":"J. Health Econ."},{"key":"99618_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/molecules25071753","volume":"25","author":"J Ziemska","year":"2020","unstructured":"Ziemska, J., Solecka, J. & Jaro\u0144czyk, M. In silico screening for novel leucine aminopeptidase inhibitors with 3,4-dihydroisoquinoline scaffold. Molecules 25, 66 (2020).","journal-title":"Molecules"},{"key":"99618_CR40","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1016\/j.bmc.2008.04.011","volume":"16","author":"AR Massah","year":"2008","unstructured":"Massah, A. R. et al. Synthesis, in vitro antibacterial and carbonic anhydrase II inhibitory activities of N-acylsulfonamides using silica sulfuric acid as an efficient catalyst under both solvent-free and heterogeneous conditions. Bioorg. Med. Chem. 16, 5465\u20135472 (2008).","journal-title":"Bioorg. Med. Chem."},{"key":"99618_CR41","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s12039-017-1337-8","volume":"129","author":"M Abbasi","year":"2017","unstructured":"Abbasi, M., Nazifi, S. M. R., Nazifi, Z. S. & Massah, A. R. Synthesis, characterization and in vitro antibacterial activity of novel phthalazine sulfonamide derivatives. J. Chem. Sci. 129, 1257\u20131266 (2017).","journal-title":"J. Chem. Sci."},{"key":"99618_CR42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1134\/S1068162020030048","volume":"46","author":"APS Bonakdar","year":"2020","unstructured":"Bonakdar, A. P. S. et al. Convenient synthesis of novel chalcone and pyrazoline sulfonamide derivatives as potential antibacterial agents. Russ. J. Bioorg. Chem. 46, 371\u2013381 (2020).","journal-title":"Russ. J. Bioorg. Chem."},{"key":"99618_CR43","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1007\/s00044-016-1585-z","volume":"25","author":"AR Massah","year":"2016","unstructured":"Massah, A. R., Gharaghani, S., Lordejani, H. A. & Asakere, N. New and mild method for the synthesis of alprazolam and diazepam and computational study of their binding mode to GABAA receptor. Med. Chem. Res. 25, 1538\u20131550 (2016).","journal-title":"Med. Chem. Res."},{"key":"99618_CR44","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1134\/S1070428019060162","volume":"55","author":"Z Rafiee Pour","year":"2019","unstructured":"Rafiee Pour, Z., Nazifi, S. M. R., Afshari Safavi, A., Nazifi, Z. S. & Massah, A. R. Solvent-free synthesis, ADME prediction, and evaluation of antibacterial activity of novel sulfonamide derivatives. Russ. J. Org. Chem. 55, 852\u2013859 (2019).","journal-title":"Russ. J. Org. Chem."},{"key":"99618_CR45","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/jccs.201800207","volume":"66","author":"F Mohebali","year":"2019","unstructured":"Mohebali, F., Nazifi, Z., Mohamad Reza Nazifi, S., Mohammadian, H. & Massah, A. R. Synthesis, molecular docking studies, and absorption, distribution, metabolism, and excretion prediction of novel sulfonamide derivatives as antibacterial agents. J. Chin. Chem. Soc. 66, 558\u201366 (2019).","journal-title":"J. Chin. Chem. Soc."},{"key":"99618_CR46","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.ejmech.2009.11.029","volume":"45","author":"ZH Chohan","year":"2010","unstructured":"Chohan, Z. H., Youssoufi, M. H., Jarrahpour, A. & Hadda, T. B. Identification of antibacterial and antifungal pharmacophore sites for potent bacteria and fungi inhibition: Indolenyl sulfonamide derivatives. Eur. J. Med. Chem. 45, 1189\u20131199 (2010).","journal-title":"Eur. J. Med. Chem."},{"key":"99618_CR47","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ejmech.2009.12.022","volume":"45","author":"M Basanagouda","year":"2010","unstructured":"Basanagouda, M. et al. Synthesis and antimicrobial studies on novel sulfonamides containing 4-azidomethyl coumarin. Eur. J. Med. Chem. 45, 1151\u20131157 (2010).","journal-title":"Eur. J. Med. Chem."},{"key":"99618_CR48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejmech.2017.04.077","volume":"136","author":"H-Z Zhang","year":"2017","unstructured":"Zhang, H.-Z. et al. Design, synthesis and antimicrobial evaluation of novel benzimidazole-incorporated sulfonamide analogues. Eur. J. Med. Chem. 136, 165\u2013183 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"99618_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-018-0479-1","volume":"12","author":"FF Al-Blewi","year":"2018","unstructured":"Al-Blewi, F. F. et al. Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1, 2, 3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents. Chem. Cent. J. 12, 1\u201314 (2018).","journal-title":"Chem. Cent. J."},{"key":"99618_CR50","first-page":"169","volume":"17","author":"AM Hira Saleem","year":"2018","unstructured":"Hira Saleem, A. M. et al. Design, synthesis, characterization and computational docking studies of novel sulfonamide derivatives. EXCLI J. 17, 169 (2018).","journal-title":"EXCLI J."},{"key":"99618_CR51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.saa.2015.05.049","volume":"150","author":"S Mondal","year":"2015","unstructured":"Mondal, S., Mandal, S. M., Mondal, T. K. & Sinha, C. Structural characterization of new Schiff bases of sulfamethoxazole and sulfathiazole, their antibacterial activity and docking computation with DHPS protein structure. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 150, 268\u2013279 (2015).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"99618_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.biopha.2017.01.036","volume":"88","author":"SS Swain","year":"2017","unstructured":"Swain, S. S., Paidesetty, S. K. & Padhy, R. N. Antibacterial activity, computational analysis and host toxicity study of thymol-sulfonamide conjugates. Biomed. Pharmacother. 88, 181\u2013193 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"99618_CR53","doi-asserted-by":"publisher","first-page":"e2322","DOI":"10.7717\/peerj.2322","volume":"4","author":"S Simeon","year":"2016","unstructured":"Simeon, S. et al. Probing the origins of human acetylcholinesterase inhibition via QSAR modeling and molecular docking. PeerJ 4, e2322 (2016).","journal-title":"PeerJ"},{"key":"99618_CR54","first-page":"173","volume":"16","author":"M Farrokhnia","year":"2017","unstructured":"Farrokhnia, M. & Mahnam, K. Molecular dynamics and docking investigations of several zoanthamine-type marine alkaloids as matrix metaloproteinase-1 inhibitors. Iran. J. Pharm. Res. 16, 173\u2013186 (2017).","journal-title":"Iran. J. Pharm. Res."},{"key":"99618_CR55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0169-7439(93)85002-X","volume":"18","author":"S de Jong","year":"1993","unstructured":"de Jong, S. SIMPLS: An alternative approach to partial least squares regression. Chemom. Intell. Lab. Syst. 18, 251\u2013263 (1993).","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"99618_CR56","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1021\/acs.jmedchem.9b01112","volume":"63","author":"DA Smithen","year":"2019","unstructured":"Smithen, D. A. et al. 2-Aminomethylene-5-sulfonylthiazole inhibitors of Lysyl Oxidase (LOX) and LOXL2 show significant efficacy in delaying tumor growth. J. Med. Chem. 63, 2308\u20132324 (2019).","journal-title":"J. Med. Chem."},{"key":"99618_CR57","first-page":"183","volume":"8","author":"S Alam","year":"2014","unstructured":"Alam, S. & Khan, F. QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase II\u03b1. Drug Des. Dev. Ther. 8, 183\u2013195 (2014).","journal-title":"Drug Des. Dev. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99618-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99618-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99618-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T19:57:47Z","timestamp":1725911867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99618-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["99618"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-99618-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"3 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20088"}}